Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does METOPROLOL Cause Product substitution issue? 570 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 570 reports of Product substitution issue have been filed in association with METOPROLOL (metoprolol succinate). This represents 1.4% of all adverse event reports for METOPROLOL.

570
Reports of Product substitution issue with METOPROLOL
1.4%
of all METOPROLOL reports
2
Deaths
67
Hospitalizations

How Dangerous Is Product substitution issue From METOPROLOL?

Of the 570 reports, 2 (0.4%) resulted in death, 67 (11.8%) required hospitalization, and 13 (2.3%) were considered life-threatening.

Is Product substitution issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for METOPROLOL. However, 570 reports have been filed with the FAERS database.

What Other Side Effects Does METOPROLOL Cause?

Drug ineffective (3,434) Dyspnoea (3,428) Dizziness (3,275) Hypotension (3,213) Completed suicide (2,959) Fatigue (2,784) Off label use (2,580) Toxicity to various agents (2,404) Bradycardia (2,024) Nausea (1,894)

What Other Drugs Cause Product substitution issue?

AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (2,832) BUPROPION (1,578) METHYLPHENIDATE (1,408) CLONAZEPAM (1,288) LAMOTRIGINE (979) ALBUTEROL (864) LEVOTHYROXINE (803) DULOXETINE (766) ESTRADIOL (692) SERTRALINE (636)

Which METOPROLOL Alternatives Have Lower Product substitution issue Risk?

METOPROLOL vs METRELEPTIN METOPROLOL vs METRONIDAZOLE METOPROLOL vs METRONIDAZOLE\METRONIDAZOLE METOPROLOL vs METYRAPONE METOPROLOL vs MEXILETINE

Related Pages

METOPROLOL Full Profile All Product substitution issue Reports All Drugs Causing Product substitution issue METOPROLOL Demographics